-
2023
-
Macrocyclic Peptidomestics Library Design and Synthesis
-
FDA creates task force to fast track COVID-19 drugs registration
-
EU Authorizes CSL’s Gene Therapy for Hemophilia B
-
Alzheimer’s Antibody Therapy from Eli Lilly Granted US FDA Breakthrough Therapy designation
-
Theravance, Viatris Seek to Block Copies of COPD Drug
-
FDA Approves Austedo XR Extended-Release Tablets for Huntington’s Disease
-
Cognition Therapeutics and ACTC Receive FDA Clearance for Phase 2 START Study of Oral CT1812 in Early Alzheimer’s Disease
-
FDA Approves First Treatment for Geographic Atrophy, Accepts NDA for Same Indication
-
Lagevrio Disappoints in Phase 3 study for Post-Exposure Prevention of COVID-19
-
Modus Therapeutics announces positive topline data from its Phase 1b LPS provocation study evaluating the potential of sevuparin for treatment of sepsis